Vasculitis

Benralizumab is noninferior to mepolizumab in achieving remission of relapsing or refractory eosinophilic granulomatosis with polyangiitis at 36 and 48 weeks, according to data published in The New England Journal of Medicine.

Is it an allergy or an autoimmune vasculitis, or a little of both? Find out the story of urticarial vasculitis, how this disease was recognized and eventually sorted out from other types of urticaria.

SCOTTSDALE, Ariz. — Recent efforts in vasculitis research have seen both “exciting” and “frustrating” results, according to data presented at the Basic and Clinical Immunology for the Busy Clinician symposium.

In this video, Audra Horomanski, MD, spoke with Healio about challenges in the vasculitis space.

In this video, Audra Horomanski, MD, discusses improving awareness of vasculitis management through provider education.

In this video, Audra Horomanski, MD, discusses the importance of collaborative care in the treatment and maintenance of patients with vasculitis.

In this video, Audra Horomanski, MD, spoke with Healio about the impact vasculitis has on the management of pregnancy.

In this video, Audra Horomanski, MD, discusses highlights in vasculitis treatment and management from recent conferences.

In this episode of Meeting Mic, we bring you Healio’s top headlines from ACR Convergence 2023.